BHVN

Biohaven Pharmaceutical Holding Company Ltd.
BHVN

Overview Fund Activity
Delisted

BHVN was delisted on the 3rd of October, 2022.

Back to rankings

90 hedge funds and large institutions have $523M invested in Biohaven Pharmaceutical Holding Company Ltd. in 2017 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 31 increasing their positions, 14 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
90
Holders Change
+15
Holders Change %
+20%
% of All Funds
2.04%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.11%
New
29
Increased
31
Reduced
14
Closed
14
Calls
$4.24M
Puts
$872K
Net Calls
+$3.37M
Net Calls Change
+$2.58M

Top Buyers

1
AllianceBernstein
AllianceBernstein
Tennessee
+$19.8M
2
GPP
Great Point Partners
Connecticut
+$13.5M
3
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$11.9M
4
PAMU
Pictet Asset Management (UK)
United Kingdom
+$8.6M
5
CAM
Cormorant Asset Management
Massachusetts
+$8.04M

Top Sellers

1
YU
Yale University
Connecticut
-$9.35M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$8.28M
3
NIP
Nicholas Investment Partners
California
-$3.6M
4
GGHC
Gilder Gagnon Howe & Co
New York
-$2.79M
5
Bank of America
Bank of America
North Carolina
-$2.04M
Name Holding Trade Value Shares
Change 		Shares
Change %
CCA
101
Catalyst Capital Advisors
New York
– -$10K -270 Closed
Fifth Third Bancorp
102
Fifth Third Bancorp
Ohio
– -$10K -260 Closed
MIM
103
Monashee Investment Management
Massachusetts
– -$748K – –
1 2 3 4
5